Low Immunogenicity in Patients with Giant Cell Arteritis Treated with Tocilizumab: 3-Year Results from the Randomized Controlled Portion and the Open-Label Follow-Up of a Phase 3 Trial

被引：0
|
作者：
Stone, John H. [1 ]
Mallalieu, Navita L. [2 ]
Bao, Min [3 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA 02115 USA
[2] Roche Innovat Ctr, New York, NY USA
[3] Genentech Inc, San Francisco, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1924
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Characteristics of Giant Cell Arteritis Flares After Successful Treatment with Tocilizumab: Results from the Long-Term Extension of a Randomized Controlled Phase 3 Trial
    Unizony, Sebastian
    Mohan, Shalini V.
    Han, Jian
    Stone, John H.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [32] Hemorrhoidal dearterialization with mucopexy versus hemorrhoidectomy: 3-year follow-up assessment of a randomized controlled trial
    Denoya, P.
    Tam, J.
    Bergamaschi, R.
    TECHNIQUES IN COLOPROCTOLOGY, 2014, 18 (11) : 1081 - 1085
  • [33] Proximal carious lesions infiltration—a 3-year follow-up study of a randomized controlled clinical trial
    Rodrigo Alex Arthur
    Julio Eduardo Zenkner
    Jose Carlos d’Ornellas Pereira Júnior
    Rafaela Trevisan Correia
    Luana Severo Alves
    Marisa Maltz
    Clinical Oral Investigations, 2018, 22 : 469 - 474
  • [34] Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results from the Open-Label Period of a Phase 3 Trial
    Khanna, Dinesh
    Lin, Celia J. F.
    Spotswood, Helen
    Siegel, Jeffrey
    Furst, Daniel
    Denton, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [35] Hemorrhoidal dearterialization with mucopexy versus hemorrhoidectomy: 3-year follow-up assessment of a randomized controlled trial
    P. Denoya
    J. Tam
    R. Bergamaschi
    Techniques in Coloproctology, 2014, 18 : 1081 - 1085
  • [36] 3-Year Follow-up of Clinical and Behavioral Improvements Following a Multifaceted Diabetes Care Intervention Results of a Randomized Controlled Trial
    Piatt, Gretchen A.
    Anderson, Robert M.
    Brooks, Maria M.
    Songer, Thomas
    Siminerio, Linda M.
    Korytkowski, Mary M.
    Zgibor, Janice C.
    DIABETES EDUCATOR, 2010, 36 (02): : 301 - 309
  • [37] An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up
    Utsunomiya, Masako
    Dobashi, Hiroaki
    Odani, Toshio
    Saito, Kazuyoshi
    Yokogawa, Naoto
    Nagasaka, Kenji
    Takenaka, Kenchi
    Soejima, Makoto
    Sugihara, Takahiko
    Hagiyama, Hiroyuki
    Hirata, Shinya
    Matsui, Kazuo
    Nonomura, Yoshinori
    Kondo, Masahiro
    Suzuki, Fumihito
    Nawata, Yasushi
    Tomita, Makoto
    Kihara, Mari
    Yokoyama-Kokuryo, Waka
    Hirano, Fumio
    Yamazaki, Hayato
    Sakai, Ryoko
    Nanki, Toshihiro
    Koike, Ryuji
    Miyasaka, Nobuyuki
    Harigai, Masayoshi
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2020, 4 (02)
  • [38] FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - RESULTS FROM 3-YEAR FOLLOW-UP
    CLEMENS, JD
    SACK, DA
    HARRIS, JR
    VANLOON, F
    CHAKRABORTY, J
    AHMED, F
    RAO, MR
    KHAN, MR
    YUNUS, M
    HUDA, N
    STANTON, BF
    KAY, BA
    WALTER, S
    EECKELS, R
    SVENNERHOLM, AM
    HOLMGREN, J
    LANCET, 1990, 335 (8684): : 270 - 273
  • [39] A two-year follow-up of oral antioxidant supplementation in primary open-angle glaucoma: an open-label, randomized, controlled trial
    Javier Garcia-Medina, Jose
    Garcia-Medina, Manuel
    Garrido-Fernandez, Pablo
    Galvan-Espinosa, Jose
    Garcia-Maturana, Carlos
    Zanon-Moreno, Vicente
    Dolores Pinazo-Duran, Maria
    ACTA OPHTHALMOLOGICA, 2015, 93 (06) : 546 - 554
  • [40] Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
    Jabbour, Elias
    Kantarjian, Hagop M.
    Saglio, Giuseppe
    Luis Steegmann, Juan
    Shah, Neil P.
    Boque, Concepcion
    Chuah, Charles
    Pavlovsky, Carolina
    Mayer, Jiri
    Cortes, Jorge
    Baccarani, Michele
    Kim, Dong-Wook
    Bradley-Garelik, M. Brigid
    Mohamed, Hesham
    Wildgust, Mark
    Hochhaus, Andreas
    BLOOD, 2014, 123 (04) : 494 - 500
12345